Pneumatica Bio is a Melbourne-based biotechnology start-up pioneering clinical prediction of novel therapeutics.

Nanomedicine is dynamic and inherently multidisciplinary. Our founders bring together expertise in biological automation, software development, biomedical engineering, computational modelling, and data science.

With backgrounds spanning academia and industry, our team has published influential scientific research, secured competitive grants, and pioneered quantitative and standardised approaches for evaluating carrier-based therapeutics. Combined with experience in both emerging and established technology companies in Australia and abroad, we are uniquely positioned to turn innovation into impact.

Interested in collaborating? Get in touch via contact@pneumatica.bio.